ArtuVet Animal Health Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

ArtuVet Animal Health General Information

Description

Developer and manufacturer of allergen-specific immunotherapy and pharmaceuticals. The company's allergen-specific immunotherapy and pharmaceuticals, prepared through a wealth of experience and knowledge in the field of diagnostics and the treatment of allergies, helps in the treatment of allergies in dogs by carefully studying the underlying causes and symptoms. It also focuses on a long-term effect and prevention.

Contact Information

Website
www.artuvet.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Other Consumer Non-Durables
Other Industries
Other Services (B2C Non-Financial)
Acquirer
Primary Office
  • Vijzelweg 11
  • 8243 PM Lelystad
  • Netherlands
+31 0320 000 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ArtuVet Animal Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ArtuVet Animal Health‘s full profile, request access.

Request a free trial

ArtuVet Animal Health Executive Team (1)

Name Title Board Seat Contact Info
Bram Schuit Chief Executive Officer
To view ArtuVet Animal Health’s complete executive team members history, request access »

ArtuVet Animal Health Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ArtuVet Animal Health‘s full profile, request access.

Request a free trial